ロード中...
A multicenter total therapy strategy for de novo adult Philadelphia chromosome positive acute lymphoblastic leukemia patients: final results of the GIMEMA LAL1509 protocol
The GIMEMA LAL1509 protocol, designed for adult (≥18-60 years) de novo Philadelphia chromosome positive (Ph+) acute lymphoblastic leukemia (ALL) patients, was based on dasatinib plus steroids induction - with central nervous system prophylaxis - followed by dasatinib alone in patients in complete mo...
保存先:
| 出版年: | Haematologica |
|---|---|
| 主要な著者: | , , , , , , , , , , , , , , , , , , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Fondazione Ferrata Storti
2021
|
| 主題: | |
| オンライン・アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8252956/ https://ncbi.nlm.nih.gov/pubmed/33538150 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3324/haematol.2020.260935 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|